165 related articles for article (PubMed ID: 34694536)
1. Vasomotor symptoms in midlife women with incident breast cancer: pink SWAN.
Gold EB; Crawford SL; Leung K; Greendale G; Reeves KW; Joffe H; Avis NE
Breast Cancer Res Treat; 2022 Jan; 191(1):125-135. PubMed ID: 34694536
[TBL] [Abstract][Full Text] [Related]
2. Hot Flash Frequency and Blood Pressure: Data from the Study of Women's Health Across the Nation.
Jackson EA; El Khoudary SR; Crawford SL; Matthews K; Joffe H; Chae C; Thurston RC
J Womens Health (Larchmt); 2016 Dec; 25(12):1204-1209. PubMed ID: 27404767
[TBL] [Abstract][Full Text] [Related]
3. Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation.
Hart V; Sturgeon SR; Reich N; Sievert LL; Crawford SL; Gold EB; Avis NE; Reeves KW
Cancer Causes Control; 2016 Nov; 27(11):1333-1340. PubMed ID: 27680016
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN).
Gold EB; Crawford SL; Shelton JF; Tepper PG; Crandall CJ; Greendale GA; Matthews KA; Thurston RC; Avis NE
Menopause; 2017 Jan; 24(1):9-26. PubMed ID: 27749738
[TBL] [Abstract][Full Text] [Related]
5. Does everyday discrimination account for the increased risk of vasomotor symptoms in Black women?: the Study of Women's Health Across the Nation (SWAN).
Reeves AN; Lewis TT; Hood MM; Thurston RC; Avis NE; Burnett-Bowie SM; Cortés YI; Neal-Perry G; Harlow SD
Menopause; 2024 Jun; 31(6):484-493. PubMed ID: 38595299
[TBL] [Abstract][Full Text] [Related]
6. Duration of menopausal vasomotor symptoms over the menopause transition.
Avis NE; Crawford SL; Greendale G; Bromberger JT; Everson-Rose SA; Gold EB; Hess R; Joffe H; Kravitz HM; Tepper PG; Thurston RC;
JAMA Intern Med; 2015 Apr; 175(4):531-9. PubMed ID: 25686030
[TBL] [Abstract][Full Text] [Related]
7. Predictors of vasomotor symptoms among breast cancer survivors.
Reeves KW; Pennell M; Foraker RE; Crandall CJ; Stefanick M; Paskett ED
J Cancer Surviv; 2018 Jun; 12(3):379-387. PubMed ID: 29427202
[TBL] [Abstract][Full Text] [Related]
8. Vasomotor symptoms and menopause: findings from the Study of Women's Health across the Nation.
Thurston RC; Joffe H
Obstet Gynecol Clin North Am; 2011 Sep; 38(3):489-501. PubMed ID: 21961716
[TBL] [Abstract][Full Text] [Related]
9. Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies.
Thurston RC
Climacteric; 2024 Feb; 27(1):75-80. PubMed ID: 37577812
[TBL] [Abstract][Full Text] [Related]
10. Identifying women who share patterns of reproductive hormones, vasomotor symptoms, and sleep maintenance problems across the menopause transition: group-based multi-trajectory modeling in the Study of Women's Health Across the Nation.
Matthews KA; Chang Y; Brooks MM; Crawford SL; Janssen I; Joffe H; Kravitz HM; Thurston RC; El Khoudary SR
Menopause; 2020 Oct; 28(2):126-134. PubMed ID: 33038144
[TBL] [Abstract][Full Text] [Related]
11. The longitudinal relation of inflammation to incidence of vasomotor symptoms.
Gold EB; Xing G; Avis NE; Harlow S; Joffe H; Matthews K; Pavlovic JM; Thurston RC; Waetjen E
Menopause; 2022 Aug; 29(8):894-904. PubMed ID: 35905469
[TBL] [Abstract][Full Text] [Related]
12. Impact of lifetime lactation on the risk and duration of frequent vasomotor symptoms: A longitudinal dose-response analysis.
Scime NV; Shea AK; Faris PD; Brennand EA
BJOG; 2023 Jan; 130(1):89-98. PubMed ID: 35993429
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the trajectories of vasomotor symptoms across the menopausal transition.
Tepper PG; Brooks MM; Randolph JF; Crawford SL; El Khoudary SR; Gold EB; Lasley BL; Jones B; Joffe H; Hess R; Avis NE; Harlow S; McConnell DS; Bromberger JT; Zheng H; Ruppert K; Thurston RC
Menopause; 2016 Oct; 23(10):1067-74. PubMed ID: 27404029
[TBL] [Abstract][Full Text] [Related]
14. Phytoestrogen and fiber intakes in relation to incident vasomotor symptoms: results from the Study of Women's Health Across the Nation.
Gold EB; Leung K; Crawford SL; Huang MH; Waetjen LE; Greendale GA
Menopause; 2013 Mar; 20(3):305-14. PubMed ID: 23435028
[TBL] [Abstract][Full Text] [Related]
15. Association between vasomotor symptom frequency and weight gain in the Study of Women's Health Across the Nation.
Gibson CJ; Shiozawa A; Epstein AJ; Han W; Mancuso S
Menopause; 2023 Jul; 30(7):709-716. PubMed ID: 37314873
[TBL] [Abstract][Full Text] [Related]
16. Adipokines, adiposity, and vasomotor symptoms during the menopause transition: findings from the Study of Women's Health Across the Nation.
Thurston RC; Chang Y; Mancuso P; Matthews KA
Fertil Steril; 2013 Sep; 100(3):793-800. PubMed ID: 23755948
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants predictive of reproductive aging are associated with vasomotor symptoms in a multiracial/ethnic cohort.
Zhao W; Smith JA; Yu M; Crandall CJ; Thurston RC; Hood MM; Ruiz-Narvaez E; Peyser PA; Kardia SLR; Harlow SD
Menopause; 2021 Apr; 28(8):883-892. PubMed ID: 33906203
[TBL] [Abstract][Full Text] [Related]
18. Menopausal Vasomotor Symptoms and Risk of Incident Cardiovascular Disease Events in SWAN.
Thurston RC; Aslanidou Vlachos HE; Derby CA; Jackson EA; Brooks MM; Matthews KA; Harlow S; Joffe H; El Khoudary SR
J Am Heart Assoc; 2021 Feb; 10(3):e017416. PubMed ID: 33470142
[TBL] [Abstract][Full Text] [Related]
19. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
[TBL] [Abstract][Full Text] [Related]
20. Vasomotor symptom characteristics: are they risk factors for incident diabetes?
Gray KE; Katon JG; LeBlanc ES; Woods NF; Bastian LA; Reiber GE; Weitlauf JC; Nelson KM; LaCroix AZ
Menopause; 2018 May; 25(5):520-530. PubMed ID: 29206771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
